Clinical Trial Update: Safety of Pentoxifylline and Vitamin E With Stereotactic Ablative Radiotherapy (SABR) in Non-small Cell Lung Cancers [Phase 2]

View source ↗

Summary

Phase 2 trial update assessing safety of pentoxifylline and vitamin E with SABR in non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Pentoxifylline (pentoxifylline)
• Vitamin E (tocopherol)

Snippet

Sponsor: University of Louisville | Conditions: Non-small Cell Lung Cancers | Phase 2 | Status: UNKNOWN